Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma

the SHINE Investigators

Research output: Contribution to journalArticlepeer-review

73 Scopus citations

Fingerprint

Dive into the research topics of 'Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences